Generation 2 Dual GLP-1/GIP Agonists (Tirzepatide) Tirzepatide was the first dual-agonist incretin peptide to reach advanced clinical research
These are medications for chronic diseases like diabetes and obesity so we dont want to just use them willy-nilly, said Haftman
Novo Nordisk now partners with Ro, Hims & Hers, and LifeMD to distribute branded Wegovy through Novos mail-order pharmacy, often at discounted cash-pay rates (~$499 per month) for patients lacking insurance coverage or prior authorization
Antibodies to exenatide did not cross-react with human GLP-1 or glucagon or alter the efficacy or safety of exenatide [abstract 858]
Like any medical intervention, they require thoughtful use, adequate nutrition, strength training, and guidance from a qualified healthcare professional
The only GHRH analog with clinical marketing authorization (FDA Egrifta 2010 for HIV-associated lipodystrophy, EGRIFTA WR F8 March 2026)